<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30262052</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-3573</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>191</Volume>                    <PubDate>                        <Year>2019</Year>                        <Month>Jan</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Talanta</Title>                <ISOAbbreviation>Talanta</ISOAbbreviation>            </Journal>            <ArticleTitle>A barcode mode based on glycosylation sites of membrane type mannose receptor as a new potential diagnostic marker for breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>21-26</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0039-9140(18)30833-6</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.talanta.2018.08.022</ELocationID>            <Abstract>                <AbstractText>Breast cancer is recognized as a heterogeneous cancer in female patients worldwide. The discovery of a new biomarker for breast cancer diagnosis is urgently needed. According to our preliminary molecular biology experiment data, we discovered that the membrane type mannose receptor (MR) was highly expressed in breast cancer patients serum, and not detected in normal human serum. Because membrane type MR was differentially expressed in four types of breast cancer, we assume that membrane type MR could be used to distinguish four types of breast cancer. Therefore, we systematically analyzed the glycosylation of membrane type MR by mass spectrometry. Six glycosylation sites were identified, among them five were newly identified in this study. A barcode mode was established based on these six glycosylation sites. Based on the barcode mode, four types of breast cancer could be easily distinguished by using the barcode mode. Interestingly, the Triple Negative Breast Cancer (TNBC), which is usually difficult to identify, can be clearly distinguished from the other subtypes of breast cancer through this barcode mode.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Fang</LastName>                    <ForeName>Jing</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tao</LastName>                    <ForeName>Tao</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Ying</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China; Key Laboratory of Glycoconjugates Research Ministry of Public Health, Fudan University, Shanghai 200032, PR China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lu</LastName>                    <ForeName>Haojie</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China; Department of Chemistry, Fudan University, Shanghai 200433, PR China; Key Laboratory of Glycoconjugates Research Ministry of Public Health, Fudan University, Shanghai 200032, PR China. Electronic address: luhaojie@fudan.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>07</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Talanta</MedlineTA>            <NlmUniqueID>2984816R</NlmUniqueID>            <ISSNLinking>0039-9140</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D037241">Mannose-Binding Lectins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C033640">mannose receptor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.4</RegistryNumber>                <NameOfSubstance UI="D014357">Trypsin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D037241" MajorTopicYN="N">Mannose-Binding Lectins</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014357" MajorTopicYN="N">Trypsin</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Barcode</Keyword>            <Keyword MajorTopicYN="N">Biomarker</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Glycosylation</Keyword>            <Keyword MajorTopicYN="N">Mannose receptor</Keyword>            <Keyword MajorTopicYN="N">Mass spectrometry</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30262052</ArticleId>            <ArticleId IdType="pii">S0039-9140(18)30833-6</ArticleId>            <ArticleId IdType="doi">10.1016/j.talanta.2018.08.022</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>